PATENT CLAIM ANALYSIS

Application Number: 15995045
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "184100"]

Abstract:
A method to prevent, inhibit or treat one or more symptoms associated with a disease of the central nervous system by intrathecally, intracerebroventricularly or endovascularly administering a rAAV encoding a gene product associated with the disease, e.g., a mammal in which the gene product is absent or present at a reduced level relative to a mammal without the disease.

Claim (Index 7):
The method of  claim 1  wherein rAAV9 vector is administered.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.52381
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14889750', '14103597', '13465575', '11057410', '14907776']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8057878750630406
- 35 USC 102 Novelty (BERT): 0.7398870794778202
- Combined Prediction Score: 0.7991977955045185
- Mean Citation Score: 505.67742000000015
- Max Citation Score: 840.0383
- Similarity Product: 789.137601380986

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test